Cell Therapeutics out to raise $40M

Cell Therapeutics is looking to raise around $40 million through the sale of stock as it seeks an FDA approval on its latest cancer therapy. Xconomy notes the Seattle-based company has raised $1.3 billion over 18 years without consistently turning a profit. Report